granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales
Q3–2020 Balance by Quarter Change Q3–20 Q2–20 Q3–19 Q3–20 VS Q2–20 Q3–20 VS Q3–19 (Million Baht: MB) (MB) % (MB) % Total Revenue 2,241.1 1,187.6 1,798.9 1,053.5 88.7 442.2 24.6 Total Operating Expenses
Three Months period ended 31 December (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 31 December 2018 2019 THB mm % THB mm % THB mm
. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 June (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30
effective since 1 January 2019. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 September (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease
processes throughout the Company. 4. Financial Position of the Company and its Subsidiaries Unit : Million Baht 31/3/2020 31/12/2019 % change Cash and cash equivalents 100 119 (16%) Account receivables 828
kiosks, which help people not to move far from their home area. Nevertheless, the Covid-19 pandemic can be viewed as a catalyst to accelerate the change of consumer behavior, which will result to a “New
benefit expenses For Quarter 2 of the year 2020, the management benefit was 3.24 million baht compare to 3.77 million baht, decrease by 0.53 million or 14.06% decreased because the company had adjust the